🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The objective of this study was to investigate the bioequivalence of Mylan'...
Status
Completed
Location
PRACS Institute, Ltd.
Start Date
2005-12
Trial ID
NCT00648219
Treatments Being Tested
The investigators want to find out whether a recently introduced combinatio...
Status
Completed
Location
Praxis Dr. Loddo
Start Date
2011-12
Trial ID
NCT01613209
Treatments Being Tested
The purpose of this study is to determine the safety and efficacy of azilsa...
Status
Completed
Location
Multiple Locations
Start Date
2004-08
Trial ID
NCT00759551
Treatments Being Tested
To assess the efficacy of individually optimized doses of olmesartan medoxo...
Status
Completed
Location
Multiple Locations
Start Date
2003-06
Trial ID
NCT00751751
The objective of this study was to investigate the bioequivalence of Mylan'...
Status
Completed
Location
PRACS Institute Ltd.
Start Date
2006-11
Trial ID
NCT01019590
The purpose of the study is to evaluate the effectiveness and safety of olm...
Status
Completed
Location
Multiple Locations
Start Date
2003-04
Trial ID
NCT00141453
Treatments Being Tested
This single dose study was designed in accordance with EMA (the European Me...
Status
Unknown
Location
Altasciences Company Inc.
Start Date
2019-10-31
Trial ID
NCT04138888
The primary objective of this study was to assess the anti-hypertensive eff...
Status
Completed
Location
Multiple Locations
Start Date
2007-07
Trial ID
NCT00441350
Treatments Being Tested
The purpose of this study is to determine whether olmesartan medoxomil is e...
Status
Unknown
Location
Chinese PLA General Hospital
Start Date
2014-12
Trial ID
NCT02360956
Treatments Being Tested
This single dose study is designed in accordance with EMA (the European Med...
Status
Completed
Location
Altasciences Company Inc.
Start Date
2019-05-06
Trial ID
NCT03951051
Treatments Being Tested